Beth Drolet is a Dermatology physician affiliated with University of Wisconsin System. OpenAlex indexes 294 publications with 20,917 citations (h-index 67); ClinicalTrials.gov lists 7 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Longitudinal Study of Neurologic, Cognitive, and Radiologic Outcomes of PHACE Syndrome
Sponsor: Medical College of Wisconsin
- Registry for Vascular Anomalies Associated With Coagulopathy
Sponsor: Medical College of Wisconsin
- Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated Hemangiomas
Sponsor: Medical College of Wisconsin
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
3 NIH research awards on record, funded 2007–2011 per NIH RePORTER. The latest:
- Safety Monitoring for Use of Propranolol for Hemangiomas
Medical College of Wisconsin
FY2011$174,875R34AR060881 - Interdisciplinary Workshop on Vascular Anomalies Associated with Coagulopathies
Medical College of Wisconsin
FY2011$27,500R13AR061943 - Phase II Clinical Trial Assessing Efficacy and Safety of Oral Steroids vs. Vincri
Medical College of Wisconsin
FY2008$349,887R01FD003429
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Proceedings of the National Academy of Sciences
2022 - Autoantibodies against type I IFNs in patients with critical influenza pneumonia
The Journal of Experimental Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Amish Raval, MD
University of Wisconsin System
David Bluemke, MD
University of Wisconsin System
David Andes, MD
University of Wisconsin System
Cynthia Carlsson, MD
University of Wisconsin System
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”